At a glance
ClinicalIndex Comparison RecordN/ACompleted· 26 enrolled
Drug / intervention
Oral glucose tolerance testother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Antihypertensive Medication Exposure as Risk for Impaired Glucose Tolerance: A PEAR Sub-Study
In Brief
An observational study evaluating Oral glucose tolerance test for Prediabetic State. Completed, enrolled 26 participants across 1 site.
Detailed Summary
The purpose of this study is to determine if, in a subset of patients treated with a beta-blocker and diuretic, prediabetes is detectable to a greater extent through a 2-hour oral glucose tolerance test (OGTT) compared to fasting glucose measurement.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPrediabetic State
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartMay 2009
First PostedApr 2010
Primary CompletionDec 2010
TodayJul 2026
First PostedApr 7, 2010
Enrollment StartMay 1, 2009
Primary CompletionDec 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 16.2 years ago
Interventions
Oral glucose tolerance testother
For assessment of dysglycemia, 75 grams of glucose solution by mouth at 3 PEAR study visits for all enrolled participants: baseline, single drug therapy assessment, and dual drug therapy assessment.